KR101605085B1 - Fermented pills comprising artemisia annua and method for preparing the same - Google Patents
Fermented pills comprising artemisia annua and method for preparing the same Download PDFInfo
- Publication number
- KR101605085B1 KR101605085B1 KR1020130160211A KR20130160211A KR101605085B1 KR 101605085 B1 KR101605085 B1 KR 101605085B1 KR 1020130160211 A KR1020130160211 A KR 1020130160211A KR 20130160211 A KR20130160211 A KR 20130160211A KR 101605085 B1 KR101605085 B1 KR 101605085B1
- Authority
- KR
- South Korea
- Prior art keywords
- lactobacillus
- lactic acid
- fermentation
- fermented
- weight
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 5
- 235000001405 Artemisia annua Nutrition 0.000 title description 3
- 240000000011 Artemisia annua Species 0.000 title description 3
- 239000006187 pill Substances 0.000 title 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 86
- 238000000855 fermentation Methods 0.000 claims abstract description 52
- 230000004151 fermentation Effects 0.000 claims abstract description 52
- 239000004310 lactic acid Substances 0.000 claims abstract description 46
- 241000894006 Bacteria Species 0.000 claims abstract description 45
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 43
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 32
- 238000004519 manufacturing process Methods 0.000 claims abstract description 18
- 235000015872 dietary supplement Nutrition 0.000 claims abstract description 14
- 240000006891 Artemisia vulgaris Species 0.000 claims description 42
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 40
- 239000000843 powder Substances 0.000 claims description 28
- 239000000047 product Substances 0.000 claims description 26
- 239000000203 mixture Substances 0.000 claims description 20
- 239000002994 raw material Substances 0.000 claims description 18
- 235000000346 sugar Nutrition 0.000 claims description 16
- 238000001035 drying Methods 0.000 claims description 12
- 235000013339 cereals Nutrition 0.000 claims description 8
- 239000004615 ingredient Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 7
- 241000186605 Lactobacillus paracasei Species 0.000 claims description 7
- 239000005913 Maltodextrin Substances 0.000 claims description 7
- 229920002774 Maltodextrin Polymers 0.000 claims description 7
- 239000006071 cream Substances 0.000 claims description 7
- 239000008103 glucose Substances 0.000 claims description 7
- 229940035034 maltodextrin Drugs 0.000 claims description 7
- 235000013311 vegetables Nutrition 0.000 claims description 7
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 6
- 241000186012 Bifidobacterium breve Species 0.000 claims description 6
- 241001608472 Bifidobacterium longum Species 0.000 claims description 6
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 6
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 6
- 244000199885 Lactobacillus bulgaricus Species 0.000 claims description 6
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims description 6
- 244000199866 Lactobacillus casei Species 0.000 claims description 6
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 6
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 6
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 6
- 241000186604 Lactobacillus reuteri Species 0.000 claims description 6
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 6
- 241000194017 Streptococcus Species 0.000 claims description 6
- 229940002008 bifidobacterium bifidum Drugs 0.000 claims description 6
- 229940041514 candida albicans extract Drugs 0.000 claims description 6
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 6
- 229940004208 lactobacillus bulgaricus Drugs 0.000 claims description 6
- 229940017800 lactobacillus casei Drugs 0.000 claims description 6
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 6
- 229940001882 lactobacillus reuteri Drugs 0.000 claims description 6
- 238000010298 pulverizing process Methods 0.000 claims description 6
- 239000012138 yeast extract Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 5
- 240000000111 Saccharum officinarum Species 0.000 claims description 4
- 235000007201 Saccharum officinarum Nutrition 0.000 claims description 4
- 239000008213 purified water Substances 0.000 claims description 4
- 240000004922 Vigna radiata Species 0.000 claims description 2
- 235000010721 Vigna radiata var radiata Nutrition 0.000 claims description 2
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 claims description 2
- 239000012535 impurity Substances 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 238000012216 screening Methods 0.000 claims 1
- 241000233866 Fungi Species 0.000 abstract description 15
- 235000013305 food Nutrition 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 6
- 230000001939 inductive effect Effects 0.000 abstract description 3
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 28
- 244000005700 microbiome Species 0.000 description 15
- 230000029087 digestion Effects 0.000 description 10
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 8
- 230000009102 absorption Effects 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 8
- 230000009286 beneficial effect Effects 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 230000000144 pharmacologic effect Effects 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 206010012601 diabetes mellitus Diseases 0.000 description 6
- 240000006766 Cornus mas Species 0.000 description 5
- 241000186840 Lactobacillus fermentum Species 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 229940009291 bifidobacterium longum Drugs 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 5
- 229940107187 fructooligosaccharide Drugs 0.000 description 5
- 229940012969 lactobacillus fermentum Drugs 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 235000013336 milk Nutrition 0.000 description 5
- 239000008267 milk Substances 0.000 description 5
- 210000004080 milk Anatomy 0.000 description 5
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 4
- 235000003097 Artemisia absinthium Nutrition 0.000 description 4
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 239000001138 artemisia absinthium Substances 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 4
- 240000005109 Cryptomeria japonica Species 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 150000002772 monosaccharides Chemical class 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 235000015140 cultured milk Nutrition 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 235000006694 eating habits Nutrition 0.000 description 2
- 230000008821 health effect Effects 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 238000004898 kneading Methods 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000005416 organic matter Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 241000254032 Acrididae Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 244000019459 Cynara cardunculus Species 0.000 description 1
- 235000019106 Cynara scolymus Nutrition 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000221785 Erysiphales Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000222418 Lentinus Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 241000282341 Mustela putorius furo Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000269821 Scombridae Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 239000003430 antimalarial agent Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229940125716 antipyretic agent Drugs 0.000 description 1
- BLUAFEHZUWYNDE-NNWCWBAJSA-N artemisinin Chemical compound C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2OC(=O)[C@@H]4C BLUAFEHZUWYNDE-NNWCWBAJSA-N 0.000 description 1
- 229960004191 artemisinin Drugs 0.000 description 1
- 229930101531 artemisinin Natural products 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000016520 artichoke thistle Nutrition 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000019985 fermented beverage Nutrition 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 239000002874 hemostatic agent Substances 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 235000020640 mackerel Nutrition 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- -1 polyphenol compound Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/50—Polysaccharides, gums
- A23V2250/51—Polysaccharide
- A23V2250/5114—Dextrins, maltodextrins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/24—Lactobacillus brevis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/25—Lactobacillus plantarum
Abstract
본 발명은 개똥쑥 발효환 및 그 제조방법에 관한 것으로, 더욱 상세하게는 개똥쑥에 효모 및 유산균을 접종하여 발효시킴으로써, 곡류 및 당분 등 부재료 없이 제환될 수 있고, 100%에 가까운 개똥쑥 함량을 구현하며, 소화흡수율이 매우 높고, 원활한 배변활동을 유도하여 건강보조식품으로서 매우 유용하게 이용될 수 있는 개똥쑥 발효환 및 그 제조방법에 관한 것이다.More particularly, the present invention relates to a method for producing a fermentation broth and a method for producing the same, and more particularly, to a method for producing a fermentation broth of a fungus, and more particularly to a fungus fermented by fermenting a fermented yeast or a lactic acid bacterium, The present invention also relates to a method for producing the same, and a method for producing the same, which is very useful as a health supplement food by inducing smooth bowel activity.
Description
본 발명은 개똥쑥 발효환 및 그 제조방법에 관한 것으로, 더욱 상세하게는 개똥쑥에 효모 및 유산균을 접종하여 발효시킴으로써, 곡류 및 당분 등 부재료 없이 제환될 수 있고, 100%에 가까운 개똥쑥 함량을 구현하며, 소화흡수율이 매우 높고, 원활한 배변활동을 유도하여 건강보조식품으로서 매우 유용하게 이용될 수 있는 개똥쑥 발효환 및 그 제조방법에 관한 것이다.
More particularly, the present invention relates to a method for producing a fermentation broth and a method for producing the same, and more particularly, to a method for producing a fermentation broth of a fungus, and more particularly to a fungus fermented by fermenting a fermented yeast or a lactic acid bacterium, The present invention also relates to a method for producing the same, and a method for producing the same, which is very useful as a health supplement food by inducing smooth bowel activity.
사회경제적인 환경의 변화로 생활패턴이 고속화됨에 따라 식생활 구조 또한 고칼로리 위주로 인스턴트화되고 있으며, 이로 인해 각종 성인병에 대한 보고가 급증하고 있다. 특히 당뇨, 고혈압, 동맥경화, 심장질환, 고지혈증 등의 성인병과 각종 암, 악성종양, 심장병, 신장병 등의 발병이 증가하여 심각한 상태에 이르고 있다.As the life patterns are speeded up due to changes in the socioeconomic environment, the dietary life structure is also being instantiated with high calorie content, and the reports on various adult diseases are increasing rapidly. In particular, serious diseases such as diabetes, hypertension, arteriosclerosis, heart disease, hyperlipidemia and various diseases such as cancer, malignant tumor, heart disease and kidney disease are increasing.
또한, 식생활 습관이 질병과 매우 밀접한 관계가 있다는 과학적 증거가 속속 드러나면서 식생활을 포함한 생활양식의 변화를 통해 건강을 증진시키고자 하는 소비자들이 빠르게 늘어나고 있다. In addition, scientific evidence that dietary habits are closely related to diseases is rapidly emerging, and consumers are increasingly seeking to improve their health through lifestyle changes, including dietary habits.
이에, 각종 질병을 예방하고 치료에 도움을 줄 수 있는 건강보조식품 내지 기능성 식품에 대한 관심이 증폭하고 있다.
Accordingly, there is a growing interest in health supplements and functional foods that can prevent and treat various diseases.
개똥쑥(Artemisia annua)은 쌍떡잎식물 초롱꽃목 국화과에 속하는 일년생 초본으로서 잔잎쑥, 개땅쑥 또는 비쑥으로도 지칭되며, 우리나라에서도 전국 각지의 야산, 길가, 들판, 강가 등에 야생하고 있다. 개똥쑥은 높이가 약 1m이며 풀 전체에 털이 없고 특이한 냄새가 나는 식물로서, 한방에서는 해열제, 지혈제, 피부병 치료제, 살충제 등으로 사용되어 왔으며, 서양에서는 마취제, 양념, 식초의 방향제 등으로 쓰여져 왔다. Artemisia annua ) is a perennial herb that belongs to the dicotyledonous plant L. lentinus, and is also referred to as Leaf Leaf Mugwort, Leaf Leaf Leaf Leaf, or Leaf Leaf Leaf. In Korea, it is also wild in wild habitats, roadsides, fields and rivers all over the country. It has been used as an antipyretic agent, hemostatic agent, skin treatment agent, insecticide, etc. in the oriental medicine, and has been used as an anesthetic agent, spice, and vinegar aroma in the West.
또한, 개똥쑥은 항말라리아제인 아르테미시닌(Artemisinin)의 공급원으로 알려져 있으며, 이외에도 개똥쑥의 다양한 약리적 효과들이 각종 문헌을 통해 제시되어 있다.
In addition, it is known as a source of anti-malaria agent Artemisinin. In addition, various pharmacological effects of cryptomeria japonica are presented through various documents.
특히, 최근 개똥쑥의 항암작용과 당뇨, 고혈압 등 성인병에 대한 유리한 약리기전이 소개되면서 개똥쑥 관련 건강보조식품의 판매 및 소비가 증가하고 있다.In particular, the sales and consumption of health supplement foods related to dog mugwort have been increasing due to the recent introduction of antitumor activity of dog mugwort and favorable pharmacological mechanism for adult diseases such as diabetes and hypertension.
구체적으로, 분말 형태의 개똥쑥을 스푼으로 떠서 복용해야 하는 불편을 개선하고자, 최근에는 개똥쑥을 둥근 건식 환(丸) 형태로 제조하여 복용이 편리한 건강보조식품으로서 제공하는 경우가 늘고 있다.More specifically, in order to improve the inconvenience of taking sponge powdery mugwort with a spoon, recently, it has been increasingly proposed to produce dog mugwort in the form of a round dry ring, which is convenient to take.
이러한 개똥쑥 환은 개똥쑥 분말을 물과 함께 반죽을 한 다음 둥글게 제환(製丸)함으로써 제조된다.
These dog mugwort rings are prepared by kneading the powdered mugwort powder with water and then rounding the mugwort powder.
그러나, 상기와 같은 기존의 제환기술은 개똥쑥 원료를 반죽하기 용이한 걸죽한 상태로 만들기 위해 찹쌀, 밀가루, 콩 등 각종 곡류 및 꿀과 같은 부재료(副材料)를 첨가해야만 한다. 순수한 개똥쑥 분말만으로는 응집력이 일어나지 않아 환으로 제형될 수 없기 때문이다.However, the above conventional pumping technology must add various kinds of cereal such as glutinous rice, wheat flour, soybeans, and other ingredients such as honey in order to make the raw material of dog milk into a kneaded state easy to knead. Pure mugwort powder alone does not cause cohesion and can not be formulated into a ring.
이때, 부재료 첨가로 인해 환의 주원료가 되는 개똥쑥의 함량이 줄어들고, 특히 탄수화물과 단당류를 피해야 하는 당뇨환자에게는 이렇게 첨가된 부재료가 건강상 오히려 역효과를 초래할 수 있다.At this time, the addition of the sub ingredient reduces the content of cow mugwort, which is the major raw material of the cow, and especially the diabetic patients who have to avoid carbohydrate and monosaccharide may have adverse effects on the health.
또한, 건강보조식품의 주 소비층인 환자 내지 노년층은 고령일수록 소화효소의 분비가 감소되고 생체기능이 저하되며, 식도와 내장신경계의 퇴화에 의한 운동성 감소 및 위산분비 감소에 따라 각종 흡수장애가 발생할 확률이 높아 개똥쑥 환 알갱이를 섭취시 소화에 부담을 주는 문제가 있다.
In addition, as the main consumer of health supplements, elderly patients are more likely to have various absorption disorders due to reduced secretion of digestive enzymes, lowered vital functions, decreased motility due to esophageal and visceral degeneration, and decreased secretion of gastric acid There is a problem that it burdens the digestion when ingesting the pellet of the pellet.
이에, 개똥쑥을 이용한 건강보조식품으로서, 곡류 및 당분 등 부재료 없이도 제환될 수 있고, 개똥쑥 함량이 높으며, 소화흡수율 또한 크게 증대시킬 수 있는 새로운 개똥쑥 환에 대한 개발이 요구되는 실정이다.
Therefore, there is a need for development of a novel anti-cancer agent which can be recycled without supplementary materials such as grains and sugar, has high content of collagen, and can greatly increase digestion and absorption rate.
본 발명은 상기와 같은 종래기술의 문제점을 해결하고자 한 것으로, 곡류 및 당분 등 부재료 없이 제환될 수 있고, 100%에 가까운 개똥쑥 함량을 구현하며, 소화흡수율이 매우 높고, 원활한 배변활동을 유도하여 건강보조식품으로서 매우 유용하게 이용될 수 있는 개똥쑥 발효환을 제공하는 것을 기술적 과제로 한다.
Disclosure of Invention Technical Problem [8] Accordingly, the present invention has been made to solve the above-mentioned problems of the prior art, and it is an object of the present invention to provide a method for producing a polyphenol compound which can be poured without ingredients such as grains and sugar, It is an object of the present invention to provide a fermentation product of mugwort that can be very useful as a health supplement food.
상기한 기술적 과제를 달성하고자, 본 발명은 개똥쑥, 효모 및 유산균을 포함하여 형성된 개똥쑥 발효환을 제공한다.In order to accomplish the above-mentioned technical object, the present invention provides a mutant fermented mung bean curd comprising mushroom, yeast and lactic acid bacteria.
그리고, 상기 유산균은 Lactobacillus acidophilus , Lactobacillus bulgaricus, Lactobacillus casei , Lactobacillus fermentum , Lactobacillus paracasei, Lactobacillus plantarum , Lactobacillus rhamnosus , Lactobacillus reuteri, Bifidobacterium bifidum , Bifidobacterium breve , Bifidobacterium longum 및 Streptococcus thermophillus로 이루어진 알파혼합유산균인 것을 특징으로 하는 개똥쑥 발효환을 제공한다.The lactic acid bacteria are Lactobacillus acidophilus , Lactobacillus bulgaricus, Lactobacillus casei , Lactobacillus fermentum , Lactobacillus paracasei, Lactobacillus plantarum , Lactobacillus rhamnosus , Lactobacillus reuteri, Bifidobacterium bifidum , Bifidobacterium breve , Bifidobacterium longum and Streptococcus which is an alpha-blended lactic acid bacterium composed of thermophillus .
아울러, 상기 개똥쑥 발효환은 개똥쑥 함량이 99~99.5 중량%인 것을 특징으로 하는 개똥쑥 발효환을 제공한다.In addition, the present invention provides a fermentation product of mugwort fungus which is characterized in that the content of the mugwort is 99 to 99.5% by weight.
더불어, 상기 개똥쑥 발효환은 건강보조식품으로 사용되는 것을 특징으로 하는 개똥쑥 발효환을 제공한다.
In addition, the present invention provides a mutant fermented product of mugwort characterized in that the mutant fermented product is used as a health supplement.
또한, 본 발명의 다른 측면으로, 개똥쑥 미세가루에 효모 및 혼합유산균을 접종한 후 발효시키고, 이를 제환한 다음, 저온건조시키는 것을 특징으로 하는 개똥쑥 발효환의 제조방법을 제공한다.According to another aspect of the present invention, there is provided a method for producing a mutant ferret flavonoid, which comprises fermenting yeast and mixed lactic acid bacteria in a microflora of Sugar Capsicum, fermenting the same, and then drying at low temperature.
구체적으로, 본 발명은 S1) 개똥쑥 어린잎 원료를 선별하여 협잡물을 제거하고 세척한 다음, 건조시키는 단계; S2) 상기 건조시킨 원료를 1차 분쇄한 다음, 120~160 mesh의 미세가루로 2차 분쇄하는 단계; S3) a) 효모건조물, b) 포도당, c) Lactobacillus acidophilus , Lactobacillus bulgaricus , Lactobacillus casei , Lactobacillus fermentum , Lactobacillus paracasei , Lactobacillus plantarum , Lactobacillus rhamnosus , Lactobacillus reuteri , Bifidobacterium bifidum , Bifidobacterium breve , Bifidobacterium longum 및 Streptococcus thermophillus로 이루어진 12종 알파혼합유산균, d) 식물성크림분말, 말토덱스트린 및 프락토올리고당 중에서 선택된 1종 이상을 혼합하는 단계; S4) 얻어진 효모건조물/12종 알파혼합유산균 혼합물을 정제수와 섞어 효모유산균 혼합액을 준비하는 단계; S5) 상기 2차 분쇄한 개똥쑥 미세가루에 상기 효모유산균 혼합액을 접종한 후 발효시키는 단계; S6) 발효 후 상기 2차 분쇄한 개똥쑥 미세가루를 추가적으로 투입하여 반죽 및 제환하는 단계; 및 S7) 제환된 발효환을 45~50℃에서 저온건조시켜 개똥쑥 함량이 99~99.5 중량%인 발효환을 수득하는 단계;를 포함하는 개똥쑥 발효환의 제조방법을 제공한다.
Specifically, the present invention relates to a method for producing a leaf material, comprising the steps of: S1) S2) firstly pulverizing the dried material, and then pulverizing the pulverized material with 120-160 mesh fine powder; S3) a) yeast product, b) glucose, c) Lactobacillus acidophilus , Lactobacillus bulgaricus , Lactobacillus casei , Lactobacillus fermentum , Lactobacillus paracasei , Lactobacillus plantarum , Lactobacillus rhamnosus , Lactobacillus reuteri , Bifidobacterium bifidum , Bifidobacterium breve , Bifidobacterium longum And Streptococcus thermophillus , d) at least one selected from the group consisting of vegetable cream powder, maltodextrin and fructooligosaccharide; S4) preparing a mixture of yeast lactic acid bacteria by mixing the resulting yeast-dried product / 12-species alpha-blended lactic acid bacteria mixture with purified water; S5) fermenting the second pulverized milk powder with a mixture of the yeast lactic acid bacteria inoculated therein; S6) adding the second powdered microcrystalline sugar powder after the fermentation to knead and replenish; And S7) low-temperature drying of the fermented fermented mixture at 45 to 50 ° C. to obtain a fermented product having a crude fat content of 99 to 99.5% by weight.
본 발명의 개똥쑥 발효환은 곡류 및 당분 등 부재료를 사용하지 않고도 반죽 및 코팅을 통한 제환이 가능해진 것인바, 주원료인 개똥쑥의 함량이 99% 이상의 수준으로 크게 증대되며, 특히 탄수화물 및 단당류 섭취를 피해야 하는 당뇨환자들에게 매우 적합하게 적용될 수 있는 건강보조식품이다.The present invention has been made possible through the use of dough and coating without the use of ingredients such as grains and sugar, and the content of the main raw material, mugwort, is greatly increased to a level of 99% or more. Especially, the consumption of carbohydrate and monosaccharide It is a health supplement that can be applied very well to diabetics who should be avoided.
또한, 본 발명의 개똥쑥 발효환은 효모 및 유산균을 이용한 발효공정을 거쳐 미생물이 살아있는 형태로 제공되는바, 소화흡수율이 매우 높고 배변활동을 원활하게 한다.In addition, since the microcapsule is provided in a living form through the fermentation process using the yeast and the lactic acid bacteria, the microbial fermentation rings of the present invention have a high digestion and absorption rate, and facilitate the bowel movement.
아울러, 본 발명의 개똥쑥 발효환은 상기와 같은 미생물의 사용 및 발효를 통해, 개똥쑥 생엽(生葉)이 지니고 있는 찬 성질을 완화시키고 그 독성을 중화 및 소멸시킬 수 있다.In addition, through the use of the microorganisms and fermentation of the present invention, it is possible to alleviate the cold properties of the green leaf and neutralize and extinguish the toxicity thereof.
더불어, 본 발명의 개똥쑥 발효환은 개똥쑥의 약리학적 유효성분과 함께 인체에 유익한 영양성분을 공급하고 체질을 개선할 수 있는바, 건강증진 및 유지에 크게 기여할 수 있다.
In addition to the pharmacological efficacy of the mugwort of the present invention, the mugwort fermented beverage of the present invention can provide beneficial nutrients to the human body, improve the constitution, and contribute greatly to health promotion and maintenance.
도 1은 본 발명에 따른 개똥쑥 발효환의 제조공정을 개략적으로 나타낸 순서도이다.FIG. 1 is a flow chart schematically showing a process for producing a maltose fermentation ring according to the present invention.
이하, 본 발명에 대해 상세히 설명한다.
Hereinafter, the present invention will be described in detail.
개똥쑥 Shag 발효환Fermentation
본 발명의 개똥쑥 발효환은 개똥쑥, 효모 및 유산균을 포함하여 형성된 것이다.The fungus of the present invention is a fungus comprising the fungus, the yeast and the lactic acid bacteria.
구체적으로, 본 발명의 개똥쑥 발효환은 개똥쑥에 효모 및 유산균을 접종하여 발효시킨 것으로, 곡류 및 당분 등 부재료 없이 제환될 수 있고, 100%에 가까운 개똥쑥 함량을 구현하며, 소화흡수율이 매우 높고, 원활한 배변활동을 유도하여 건강보조식품으로서 유용하게 이용될 수 있는 것이다.
Specifically, the fungus mutant of the present invention is fermented by inoculating yeast and lactic acid bacteria into a fungus, and can be poured without any ingredient such as grains and sugar, has a fungus content close to 100%, has a very high digestion rate , And it can be used as a health supplement food by inducing smooth bowel activity.
상기 개똥쑥(Artemisia annua)은 본 발명 개똥쑥 발효환의 주원료로서, 항암효과, 노화억제효과(항산화능력), 당뇨 및 고혈압 등 성인병에 대한 유리한 약리효과를 갖는 식물이다.The artemisia annua is a plant having the beneficial pharmacological effect on adult diseases such as anticancer effect, antioxidative effect (antioxidant ability), diabetes and hypertension as the main ingredient of the present invention.
본 발명에 사용되는 개똥쑥(잔잎쑥, 개땅쑥 또는 비쑥 등으로도 지칭됨)은 쌍떡잎식물 초롱꽃목 국화과에 속하는 한해살이풀로서, 형상이 유사한 개사철쑥, 돼지풀과 개똥쑥과는 구별된다. 개똥쑥은 주로 아시아 지역에 분포해 있고, 재배시 약 1m 높이 이상 자라며, 야산이나 길가, 강가 등에서 관찰할 수 있다. 또한 개똥쑥은 풀 전체에 털이 없고 특이한 냄새가 나는 것이 특징이다.The wormwood (also called wormwood, mackerel, or wormwood) used in the present invention is an annual plant belonging to the mulberry family of the dicotyledonous plants, and is distinguished from a similar type of wormwood, porcine grasshopper, and dogwood mugwort. Cryptomeria japonica is distributed mainly in Asia, growing more than 1m height when cultivated, and can be observed in wildlife, roadside, riverside. Also, it is characterized by the unpleasant odor of the whole grass with no hairs.
본 발명에 있어서, 상기 개똥쑥 성분으로는 개똥쑥의 잎 부분을 선별하여 사용하는 것이 바람직하다. 개똥쑥 잎은 개똥쑥 줄기 대비 적게는 2배에서 많게는 5배에 달하는 영양소를 지니고 있으며, 항산화능력 또한 더욱 우수하기 때문이다(하기 표 1 참조).In the present invention, it is preferable to use the leaf portion of the mugwort as a component of the mugwort. It is because antioxidant ability is also superior (see Table 1 below).
(Ca)calcium
(Ca)
(P)sign
(P)
(Mg)magnesium
(Mg)
(Na)salt
(Na)
(K)potassium
(K)
(Fe)iron
(Fe)
(Cu)Copper
(Cu)
(Zn)zinc
(Zn)
(%)Antioxidant ability
(%)
잎Shag
leaf
줄기Shag
stem
(출처: 개똥쑥전문지도연구회)
( Source: Experimental Mapping of Dogwood Mugwort )
또한, 개똥쑥은 강력한 약리학적 효능만큼 일부 독성 성분을 함유하고 있으며, 특히 개똥쑥의 꽃이나 줄기는 식품 원료로서 아직 그 안전성이 입증되지 않은 것으로 알려져 있다. 따라서, 본 발명에서는 개똥쑥 중 잎 부분을 사용하되 다 자란 개똥쑥 잎이 아닌 어린잎만을 선별하여 사용하는 것이 가장 바람직하다.In addition, it has some toxic components as strong pharmacological efficacy. Especially, it is known that the flowers and stems of Cryptomeria japonica have not yet proved its safety as food ingredients. Therefore, in the present invention, it is most preferable to use only the leaf portion of dogwood mugwort, but to use only the young leaves that are not mugwortly mugwort leaves.
본 발명의 개똥쑥 발효환은 개똥쑥 함량이 99 중량% 이상, 예컨대 99~99.5 중량% 수준으로 매우 높은 것이다. 즉, 본 발명은 효모 및 유산균을 이용한 발효를 통해 곡류 및 당분 등 부재료를 사용하지 않고도 제환이 가능해진 것인바, 개똥쑥 100%에 가까운 고순도의 개똥쑥 환을 제공할 수 있다.The mushroom fermented product of the present invention has a mushroom content of 99 wt% or more, such as 99 to 99.5 wt%, which is very high. That is, the fermentation using the yeast and the lactic acid bacteria enables the fermentation without using the raw materials such as grains and sugar, and it can provide a high-purity dog pox that is close to 100%.
일 구체예에서, 본 발명의 개똥쑥 발효환은 개똥쑥(예컨대, 개똥쑥 어린잎) 99 중량%, 효모(예컨대, 효모건조물) 0.5 중량% 및 유산균(예컨대, 12종 알파혼합유산균) 0.5 중량%로 구성된 것일 수 있다.
In one embodiment, the fungus extract of the present invention comprises 99% by weight of fungus (for example, fungus), 0.5% by weight of yeast (for example, yeast) and 0.5% by weight of lactic acid bacteria (for example, ≪ / RTI >
상기 효모는 자신이 지닌 효소를 이용하여 유기물(예컨대, 당)을 분해함으로써 발효를 진행시키고 각종 비타민류 및 생리활성물질을 만들어내는 성분이다.The yeast is a component that promotes fermentation by decomposing an organic substance (for example, sugar) using its own enzyme and produces various vitamins and physiologically active substances.
본 발명의 개똥쑥 발효환은 종래의 설탕발효가 아닌 효모 및 유산균을 이용한 특수한 발효공정을 통해 제조되는데, 이러한 발효공정을 통해 개똥쑥의 독성이 사라지고 소화흡수율이 현저히 높아지며 이로운 토종 미생물까지 섭취할 수 있게 된다.The fermentation broth of the present invention is produced through a special fermentation process using yeast and lactic acid bacteria, rather than conventional sugar fermentation. Through the fermentation process, the toxicity of the mugwort is disappeared, the digestion rate is remarkably increased, and the beneficial native microorganism can be taken do.
상기 효모로는 효모건조물을 바람직하게 사용할 수 있으나, 반드시 이에 한정되는 것은 아니다.The yeast may be preferably a yeast-derived material, but is not limited thereto.
상기 효모의 함량은 0.25~0.5 중량%일 수 있다. 효모의 함량이 0.25 중량% 미만이면 발효가 원활히 진행되지 않거나 생성되는 생리활성물질의 양이 적어져 원하는 수준의 기능성을 구현하기 어렵거나 발효환의 소화흡수율이 다소 저하될 수 있으며, 0.5 중량%를 초과하면 개똥쑥의 상대적 함량 감소로 개똥쑥 특유의 강력한 약리효과를 최대한 발휘하기 어려워질 수 있다.
The content of the yeast may be 0.25 to 0.5% by weight. If the yeast content is less than 0.25% by weight, the fermentation does not progress smoothly or the amount of the physiologically active substance to be produced is decreased, so that the desired level of functionality may not be realized or the digestion and absorption rate of the fermented food may be lowered to some extent, The relative content of mugwort can be reduced and it may be difficult to maximize the strong pharmacological effect of mugwort.
상기 유산균은 유기물을 흡수되기 쉬운 상태로 만듦과 더불어 그 자체의 정장작용을 통해, 위장기능 및 소화기능이 약한 건강보조식품 주 소비층인 고연령층의 소화흡수율을 높이고 배변활동을 원활하게 하는데 도움을 주는 성분이다.The lactic acid bacterium has a weak gastrointestinal function and digestive function through its own formal action and also makes it easy to absorb organic matter. The ingredient which helps the digestive absorption rate of the elderly layer, which is the main consumption layer, to be.
그 결과, 본 발명의 개똥쑥 발효환 복용시 개똥쑥의 유효성분이 손실 없이 체내로 흡수될 수 있는 장점이 있다. 또한 상기 유산균은 당분을 유산으로 바꾸는 유산발효(Lactic acid fermentation)를 진행시키며, 항암물질, 항산화물질, 면역증강물질과 같은 생리활성물질을 만들어내고, 개똥쑥과 반응하여 더욱 상승적인 효과가 발현되도록 한다.As a result, there is an advantage that the effective component of the mugwort can be absorbed into the body without loss when the fermented milk of the present invention is administered. In addition, the lactic acid bacteria promotes lactic acid fermentation, which converts sugar into lactic acid, and produces physiologically active substances such as anticancer substances, antioxidants and immunostimulating substances, do.
상기 유산균으로는 2종 이상의 서로 다른 유산균이 포함된 혼합유산균을 사용하는 것이 바람직하다. 구체적으로, Lactobacillus acidophilus , Lactobacillus bulgaricus, Lactobacillus casei , Lactobacillus fermentum , Lactobacillus paracasei, Lactobacillus plantarum , Lactobacillus rhamnosus , Lactobacillus reuteri, Bifidobacterium bifidum , Bifidobacterium breve , Bifidobacterium longum 및 Streptococcus thermophillus로 이루어진 그룹에서 선택된 2종 이상의 균이 혼합된 것을 사용할 수 있으며, 상기 종류들이 (예컨대, 같은 중량비율로) 모두 혼합된 12종 알파혼합유산균을 사용하는 것이 특히 바람직하다.As the lactic acid bacteria, it is preferable to use mixed lactic acid bacteria containing two or more different lactic acid bacteria. Specifically, Lactobacillus acidophilus , Lactobacillus bulgaricus, Lactobacillus casei , Lactobacillus fermentum , Lactobacillus paracasei, Lactobacillus plantarum , Lactobacillus rhamnosus , Lactobacillus reuteri, Bifidobacterium bifidum , Bifidobacterium breve , Bifidobacterium longum and Streptococcus thermophillus , and it is particularly preferable to use 12 kinds of alpha-mixed lactic acid bacteria in which the above types are all mixed (for example, in the same weight ratio).
개똥쑥은 그 자체가 항균작용을 일부 수행하는바 균 증식 및 발효 처리가 쉽지 않다. 따라서 본 발명에서는 상기와 같은 혼합유산균의 사용을 통해 균 증식 및 발효의 효율성을 극대화시킨 것이며, 이를 통해 단일 균을 사용해 발효시킨 경우보다 수 배 더 많은 미생물을 제공할 수 있다.It is not easy to grow and ferment, which is an antimicrobial effect. Therefore, the present invention maximizes the efficiency of microbial growth and fermentation through the use of the mixed lactic acid bacteria as described above, and thus, it is possible to provide microorganisms several times more than when fermented using a single microorganism.
상기 유산균의 함량은 0.25~0.5 중량%일 수 있다. 유산균의 함량이 0.25 중량% 미만이면 소화흡수율 증가 및 원활한 배변활동 유도가 어려워지거나 생성되는 생리활성물질의 양이 적어져 원하는 수준의 기능성을 구현하기 어렵거나 발효(균 증식)가 원활히 진행되지 않을 수 있으며, 0.5 중량%를 초과하면 개똥쑥의 상대적 함량 감소로 개똥쑥 특유의 강력한 약리효과를 최대한 발휘하기 어려워질 수 있다.
The content of the lactic acid bacteria may be 0.25 to 0.5% by weight. When the content of the lactic acid bacterium is less than 0.25% by weight, it is difficult to induce an increase in the digestion and absorption rate and to induce smooth bowel activity, or the amount of the physiologically active substance to be produced is decreased, so that it is difficult to achieve a desired level of functionality or fermentation If the amount is more than 0.5% by weight, the relative content of the mugwort can be decreased, thereby making it difficult to exhibit the strong pharmacological effect unique to the mugwort.
상기와 같은 본 발명의 개똥쑥 발효환은 개똥쑥 함량, 건강기능성 및 소화흡수율이 탁월한 것인바, 일반인의 건강보조식품으로서 유용하게 적용될 수 있으며, 위장기능 및 소화기능이 약한 고연령층이나 탄수화물 및 단당류 섭취를 피해야 하는 당뇨환자들에게 특히 적합하게 적용될 수 있다.
The above-described fermented milk powder of the present invention can be effectively applied as a health supplement for the general public because it has excellent contents of mushroom, health function and digestion and absorption rate, and can be used as a health supplement for the general public. It can be particularly suitably applied to diabetic patients to be avoided.
개똥쑥 Shag 발효환의Fermented 제조방법 Manufacturing method
본 발명의 다른 측면에 따르면, 개똥쑥 미세가루에 효모 및 혼합유산균을 접종한 후 발효시키고, 이를 제환한 다음, 저온건조시키는 것을 특징으로 하는 개똥쑥 발효환의 제조방법이 제공된다.According to another aspect of the present invention, there is provided a method for producing a mutant leishmanella fungus, characterized in that yeast and mixed lactic acid bacteria are inoculated into the microcrystalline sugarcane, followed by fermentation, followed by cooling and low-temperature drying.
구체적으로, 본 발명의 개똥쑥 발효환은 S1) 개똥쑥 원료 세척 및 건조 단계; S2) 개똥쑥 원료 분쇄 단계; S3) 효모건조물/12종 알파혼합유산균 혼합물 제조 단계; S4) 효모유산균 혼합액 준비 단계; S5) 발효 단계; S6) 제환 단계; 및 S7) 저온건조 단계;를 거쳐 제조된다(도 1 참조).
Specifically, the fermentation broth of the present invention comprises S1) washing and drying of raw materials; S2) raw material pulverization step; S3) yeast-dried product / 12-species alpha mixed lactic acid bacteria mixture preparation step; S4) preparing a yeast lactic acid bacteria mixture; S5) fermentation step; S6) a pumping step; And S7) low-temperature drying step (see Fig. 1).
상기 S1) 단계는 개똥쑥 어린잎 원료를 선별하여 협잡물을 제거하고 깨끗한 용수에 세척한 다음, 건조시키는 단계이다.In the step S1), the raw material of the petiole leaf is selected, the impurities are removed, cleaned in clean water, and then dried.
전술한 바와 같이, 개똥쑥은 독성 성분을 일부 함유하고 있는바, 본 발명에서는 안전성을 담보하기 위해 개똥쑥 중 잎 부분을 사용하되 다 자란 개똥쑥 잎이 아닌 어린잎만을 선별하여 사용하도록 한다.As described above, the mushroom contains some toxic components. In order to ensure safety, the mushroom of the mushroom is used in the present invention. However, only the young leaves, which are not mushroom leaves, are selected.
또한, 개똥쑥 어린잎 원료를 건조시킬 때에는 약 60일간 그늘에서 자연건조시켜, 열건조시 발생하는 영양성분 손실을 방지하는 것이 바람직하다.
In addition, when the raw material of the young leaves is dried, it is preferable to naturally dry in the shade for about 60 days to prevent loss of nutrients caused by heat drying.
상기 S2) 단계는 제조가공할 설비를 살균 세척한 후, 건조시킨 원료를 1차 분쇄한 다음, 1차 분쇄한 원료를 120~160 mesh의 입도크기로 다시 2차 분쇄하여 미세가루로 분말화하는 단계이다.
In the step S2), the equipment to be manufactured and processed is washed and sterilized, and then the dried raw materials are firstly pulverized, and then the first pulverized raw materials are secondarily pulverized to a particle size of 120 to 160 mesh and pulverized into fine powder .
상기 S3) 단계는 a) 효모건조물, b) 포도당, c) Lactobacillus acidophilus , Lactobacillus bulgaricus , Lactobacillus casei , Lactobacillus fermentum , Lactobacillus paracasei , Lactobacillus plantarum , Lactobacillus rhamnosus , Lactobacillus reuteri , Bifidobacterium bifidum , Bifidobacterium breve , Bifidobacterium longum 및 Streptococcus thermophillus로 이루어진 12종 알파혼합유산균, d) 식물성크림분말, 말토덱스트린 및 프락토올리고당 중에서 선택된 1종 이상을 혼합하는 단계이다.Step S3) comprises the steps of: a) drying yeast, b) glucose, c) Lactobacillus acidophilus , Lactobacillus bulgaricus , Lactobacillus casei , Lactobacillus fermentum , Lactobacillus paracasei , Lactobacillus plantarum , Lactobacillus rhamnosus , Lactobacillus reuteri , Bifidobacterium bifidum , Bifidobacterium breve , Bifidobacterium longum And Streptococcus thermophillus , and d) at least one selected from vegetable cream powder, maltodextrin and fructooligosaccharide.
개똥쑥만 넣어서 발효를 하면 개똥쑥 자체의 항균작용으로 인해 발효가 잘 되지 않는바, 본 발명에서는 단일 균이 아닌 유익한 여러 가지 복합미생물을 사용하여 발효가 효율적으로 진행되도록 하며, 그 결과 복합유산균 덩어리인 어린잎 개똥쑥 발효환을 제공할 수 있게 된다. 또한 이렇게 효모건조물/12종 알파혼합유산균 혼합물을 이용한 발효공정을 거침으로써, 개똥쑥의 흡수율이 종래 일반 개똥쑥 환 대비 수십 배 증가하는바 소량만 섭취하여도 현저한 약리적 효과를 볼 수 있다.In the present invention, the fermentation is efficiently carried out using various complex microorganisms which are not single microorganisms but which are beneficial, and as a result, the complex lactic acid bacteria mass Which can provide a young leaf mugwort fermentation ring. In addition, the fermentation process using the mixture of the yeast-dried product / 12 kinds of alpha-blended lactic acid bacteria increases the water uptake rate of mugwort, which is several times higher than that of the conventional mugwort mugwort, and a remarkable pharmacological effect can be obtained even if only a small amount thereof is ingested.
상기 포도당, 식물성크림분말, 말토덱스트린(Maltodextrin) 및 프락토올리고당(Fructo-oligosaccharide) 등은 발효에 관계하는 미생물에 탄소원 및 에너지원을 공급하기 위해 첨가되는 성분이다.The glucose, vegetable cream powder, maltodextrin, and fructo-oligosaccharide are components added to supply a carbon source and an energy source to microorganisms involved in fermentation.
본 발명에서는 설탕을 사용하지 않고 효모 및 혼합유산균을 이용한 특수한 발효공정을 통해 개똥쑥 발효환을 제조하며, 이러한 발효공정을 통해 개똥쑥의 독성을 없애고 소화흡수율을 현저히 증가시키며 유익한 토종 미생물까지 섭취할 수 있는 장점이 있다.In the present invention, a special fermentation process using yeast and mixed lactic acid bacteria without sugar is used to produce a mugwort fermented product. Through this fermentation process, the toxicity of mugwort is eliminated, the digestion rate is significantly increased, and beneficial native microorganisms are consumed There are advantages to be able to.
상기 포도당, 식물성크림분말 및 말토덱스트린은 미생물의 먹이가 되는 것으로, 대사작용을 통해 가스 생성을 촉진하고 발효시간을 단축시키는 역할을 한다. 이들은 미생물이 증식함에 따라 대부분 소거되는바, 제품 복용시 잔류 당에 의한 건강상 부작용이 생길 우려가 없다.The glucose, vegetable cream powder and maltodextrin serve as food for microorganisms, and promote metabolism and accelerate gas production and shorten fermentation time. They are mostly eliminated by the proliferation of microorganisms, so there is no risk of adverse health effects due to residual sugars when the product is taken.
상기 프락토올리고당은 미생물의 먹이가 되는 것으로, 발효 촉진, 유익균 증식, 유해균 억제 및 칼슘 흡수에 도움을 주고, 배변활동을 원활하게 하는 역할을 한다. 또한 이는 미생물이 증식함에 따라 대부분 소거되는바, 제품 복용시 잔류 당에 의한 건강상 부작용이 생길 우려가 없다.The fructooligosaccharide serves as a food for microorganisms, which promotes fermentation, proliferates beneficial bacteria, inhibits harmful bacteria, absorbs calcium and plays a role in facilitating bowel movement. In addition, since it is mostly cleared by the proliferation of microorganisms, there is no possibility of adverse health effects due to residual sugar when the product is taken.
일 구체예에서, 상기 S3) 단계는 효모건조물 0.5 중량%[함수결정포도당 80 중량% + 효모건조물 20 중량%]와 12종 알파혼합유산균 0.5 중량%[식물성크림분말 45 중량% + 말토덱스트린 45 중량% (또는 프락토올리고당 90 중량%) + 상기 12종 유산균을 같은 중량비율로 혼합한 12종 알파혼합유산균 10 중량%]를 혼합하여 수행될 수 있으며, 이를 통해 결과적으로 개똥쑥 함량이 99 중량%인 발효환을 제조할 수 있다.
In step S3), 0.5% by weight of the yeast extract (80% by weight of hydrocrystalline glucose and 20% by weight of yeast extract) and 0.5% by weight of 12 kinds of alpha blended lactic acid bacteria (45% by weight of vegetable cream powder + 45% by weight of maltodextrin 10% by weight of a mixture of 12 kinds of α-lactic acid bacteria (90% by weight of fructooligosaccharide + 12 kinds of lactic acid bacteria of the same weight ratio)]. As a result, A fermentation broth can be produced.
상기 S4) 단계는 얻어진 효모건조물/12종 알파혼합유산균 혼합물을 정제수와 (예컨대, 2:8의 중량비율로) 섞어 개똥쑥 원료에 접종할 효모유산균 혼합액을 준비하는 단계이다.
Step S4) is a step of preparing a yeast lactic acid bacterium mixture to be inoculated into the raw material of dog milk by mixing the resulting yeast-dried product / 12-species alpha-lactic acid bacteria mixture with purified water (for example, at a weight ratio of 2: 8).
상기 S5) 단계는 상기 S2) 단계에서 준비된 2차 분쇄한 개똥쑥 미세가루에 상기 효모유산균 혼합액을 접종한 후 발효시키는 단계이다.The step S5) is a step of inoculating the yeast lactic acid bacteria mixture into the secondary pulverized sugar mist powder prepared in the step S2) and then fermenting.
이러한 발효공정을 통해 유기물이 저분자로 분해되어 흡수되기 쉬운 상태로 변모되는바 개똥쑥 환의 소화흡수율 높이는데 도움을 준다. 또한 발효에 사용되는 유익한 미생물들이 항산화 물질을 생성하여 부패를 막아 제품의 보존성 또한 증대시킬 수 있다.Through this fermentation process, the organic matter is transformed into a low - molecular - digestible and easily absorbable state, which helps to increase digestion and absorption rate. In addition, beneficial microorganisms used in fermentation can produce antioxidants to prevent corruption and increase the preservation of products.
일 구체예에서, 상기 S5) 단계는 2차 분쇄한 개똥쑥 미세가루를 33~37℃의 발효용기에 넣고 상기 효모유산균 혼합액을 접종한 후 밀봉 보관하여 72시간 이상(예컨대, 3일~6일) 발효시킴으로써 수행될 수 있다. 여기서, 발효온도가 33℃ 미만이면 발효기간이 길어져 공정상 효율성이 떨어질 수 있고, 37℃를 초과하면 종류에 상관없이 미생물이 증식하기에 좋은 환경이 되어 유해한 미생물에 의해 변질이나 부패가 발생할 가능성이 있다.
In one embodiment, in step S5), the second powdered sugarcane powder is placed in a fermentation vessel at 33 to 37 DEG C, and the yeast lactobacillus solution is inoculated, sealed and stored for 72 hours or more (for example, ). ≪ / RTI > If the fermentation temperature is lower than 33 ° C, the fermentation period may become longer and the efficiency of the process may deteriorate. If the temperature exceeds 37 ° C, there is a possibility that the microorganism may proliferate irrespective of the type thereof, have.
상기 S6) 단계는 발효 후 상기 2차 분쇄한 개똥쑥 미세가루를 한번 더 투입하여 발효물을 복용이 용이하도록 환의 형태로 반죽해서 제형하는 단계이다.In the step S6), the fermentation product is kneaded in the form of a ring so that the fermented product can be easily taken into the fermented product after the fermentation, and the secondarily ground granulated artichoke powder is added once more.
종래에는 개똥쑥 원료 분쇄물에 찹쌀풀, 꿀 등의 부형제(Excipient)를 첨가해야만 환의 형태로 제형이 가능하였으나, 본 발명에서는 특별한 발효공정을 통해 곡류 및 당분 등 부재료 없이도 자연스럽게 개똥쑥 원료를 제환할 수 있다. 그 결과 본 발명의 개똥쑥 발효환은 탄수화물 및 단당류 섭취를 피해야 하는 당뇨환자들도 안심하고 건강보조식품으로서 복용할 수 있는 장점이 있다.Conventionally, the excipient such as glutinous rice paste and honey has to be added to the raw ground powder of dogwood, so that it can be formulated in the form of a ring. However, in the present invention, a special fermentation process can naturally pour the dogwood raw material . As a result, the diabetic patients who have to avoid the intake of carbohydrate and monosaccharide have the advantage that they can take it as a health supplement food with ease.
또한, 본 단계에서는 발효물의 반죽 및 제환을 위해 2차 분쇄한 개똥쑥 미세가루를 한번 더 투입하는바, 이를 통해 최종 제품의 개똥쑥 함량을 한층 더 높일 수 있는 부수적 효과를 거둘 수 있다.
Also, in this step, the second-stage pulverized milk powder is added once more for kneading and pulverizing the fermented product, thereby providing a side effect of further increasing the milk powder content of the final product.
상기 S7) 단계는 제환된 발효환을 45~50℃의 저온에서 건조시켜 개똥쑥 함량이 99~99.5 중량%인 발효환을 최종적으로 수득하는 단계이다.In the step S7), the fermented fermented beans are dried at a low temperature of 45 to 50 DEG C to finally obtain a fermentation broth having a content of gall bladder of 99 to 99.5 wt%.
본 발명에서는 마무리 단계로서 발효환을 45~50℃의 저온에서 건조시키는바, 이는 고온건조시 유익한 균들이 사멸되는 것을 방지함과 더불어, 특히 발효물에 포함된 영양소 파괴를 최소화하고자 함이다. 여기서, 건조 온도가 45℃ 미만이면 건조가 원활히 진행되지 못하고 제품에 수분이 잔류하여 단위 환 당 개똥쑥 함량이 낮아질 우려가 있으며, 50℃를 초과하면 발효물의 영양소가 파괴되어 건강기능성이 저하될 수 있다.
In the present invention, as a finishing step, the fermentation rings are dried at a low temperature of 45 to 50 ° C, which prevents beneficial microorganisms from being killed at the time of high-temperature drying and minimizes nutrient destruction particularly included in fermented products. If the drying temperature is less than 45 ° C, drying may not proceed smoothly and moisture may remain in the product, which may lower the content of gallmopsite per unit. If the temperature exceeds 50 ° C, the nutrients of the fermented product may be destroyed, have.
이하, 실시예를 통해 본 발명을 보다 구체적으로 설명한다. 그러나 하기 실시예는 본 발명의 이해를 돕기 위한 것일 뿐 어떠한 의미로든 본 발명의 범위가 이들 실시예로 한정되는 것은 아니다.
Hereinafter, the present invention will be described more specifically by way of examples. However, the following examples are provided to aid understanding of the present invention, and the scope of the present invention is not limited to these examples in any sense.
실시예Example
원료로서 개똥쑥 어린잎만을 선별하여 협잡물을 제거하고 깨끗한 용수에 세척한 다음, 그늘진 곳에서 60일간 자연건조시켰다.As a raw material, only young leaves were selected to remove the contaminants, washed in clean water, and dried naturally in a shady place for 60 days.
제조가공할 설비를 살균 세척한 후, 상기 건조시킨 원료를 1차 분쇄한 다음, 1차 분쇄한 원료를 120~160 mesh의 입도크기로 2차 분쇄하여 개똥쑥 어린잎 미세가루를 준비하였다.
After the equipment to be manufactured and processed was sterilized and cleaned, the dried raw materials were firstly pulverized and then the primary pulverized raw materials were secondly pulverized with a particle size of 120 to 160 mesh to prepare a fine powder of wilted young leaves.
한편, 함수결정포도당 80 중량% 및 효모건조물 20 중량%로 구성된 효모혼합물 0.5 중량부;와 식물성크림분말 45 중량%, 말토덱스트린 45 중량% 및 12종 알파혼합유산균(Lactobacillus acidophilus , Lactobacillus bulgaricus , Lactobacillus casei, Lactobacillus fermentum , Lactobacillus paracasei , Lactobacillus plantarum, Lactobacillus rhamnosus , Lactobacillus reuteri , Bifidobacterium bifidum, Bifidobacterium breve , Bifidobacterium longum 및 Streptococcus thermophillus를 같은 중량비율로 혼합한 것) 10 중량%로 구성된 유산균혼합물 0.5 중량부;를 혼합하여 효모건조물/12종 알파혼합유산균 혼합물을 준비하였다.On the other hand, 0.5 part by weight of a yeast mixture composed of 80% by weight of hydrous crystalline glucose and 20% by weight of yeast extract, 45% by weight of vegetable cream powder, 45% by weight of maltodextrin and 12% by weight of Lactobacillus acidophilus , Lactobacillus bulgaricus , Lactobacillus casei, Lactobacillus fermentum , Lactobacillus paracasei , Lactobacillus plantarum, Lactobacillus rhamnosus , Lactobacillus reuteri , Bifidobacterium bifidum, Bifidobacterium breve , Bifidobacterium longum And Streptococcus thermophillus were mixed in the same weight ratio) to prepare a mixture of yeast extract / 12 kinds of alpha blended lactic acid bacteria.
준비된 효모건조물/12종 알파혼합유산균 혼합물을 정제수와 2:8의 중량비율로 섞어 효모유산균 혼합액을 준비하였다.
The mixture of prepared yeast extract / 12 kinds of alpha blended lactic acid bacteria was mixed with purified water at a weight ratio of 2: 8 to prepare a yeast lactic acid bacteria mixture.
앞서 준비된 2차 분쇄한 개똥쑥 미세가루 99 중량부를 33~37℃의 발효용기에 넣고 상기 효모유산균 혼합액을 접종한 후 밀봉 보관하여 3일~6일 발효시켰다.99 parts by weight of the second ground powder prepared above was put into a fermentation vessel at 33 to 37 DEG C, and the mixture was inoculated with the yeast lactic acid bacterium solution, sealed, and fermented for 3 to 6 days.
발효가 완료된 후, 앞서 준비된 2차 분쇄한 개똥쑥 미세가루를 한번 더 투입하여 발효물을 환의 형태로 반죽해서 제형하였다.After the completion of the fermentation, the above-prepared second-order pulverized powdery mildew powder was added one more time and the fermented product was kneaded in the form of a ring.
제환된 발효환을 45~50℃의 저온에서 건조시킴으로써, 곡류 및 당분의 부재료 사용 없이 개똥쑥 함량이 99 중량%인 개똥쑥 발효환 건강보조식품을 제조하였다.
The crude fermented product was dried at a low temperature of 45 to 50 ° C to produce a dietary supplement of dietary mugwort fermented with a weight of 99% by weight, without using any grains or sugar.
Claims (6)
S2) 상기 자연건조시킨 원료를 1차 분쇄한 다음, 120~160 mesh의 미세가루로 2차 분쇄하는 단계;
S3) a) 효모건조물 0.1 중량부, b) 포도당 0.4 중량부, c) Lactobacillus acidophilus, Lactobacillus bulgaricus, Lactobacillus casei, Lactobacillus fermentum, Lactobacillus paracasei, Lactobacillus plantarum, Lactobacillus rhamnosus, Lactobacillus reuteri, Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium longum 및 Streptococcus thermophillus가 같은 중량비율로 혼합된 12종 알파혼합유산균 0.05 중량부, d) 식물성크림분말 및 말토덱스트린 각 0.225 중량부를 혼합하는 단계;
S4) 상기 S3) 단계에서 얻어진 효모건조물/12종 알파혼합유산균 혼합물을 정제수와 2:8의 중량비율로 섞어 효모유산균 혼합액을 준비하는 단계;
S5) 상기 2차 분쇄한 개똥쑥 미세가루 99 중량부를 33~37℃의 발효용기에 넣고 상기 효모유산균 혼합액을 접종한 후 밀봉 보관하여 3일~6일 동안 발효시키는 단계;
S6) 발효 후 상기 S2) 단계에서 2차 분쇄한 개똥쑥 미세가루를 추가적으로 투입하여 반죽 및 제환하는 단계; 및
S7) 제환된 발효환을 45~50℃에서 저온건조시켜 개똥쑥 함량이 99 중량%인 발효환을 수득하는 단계;를 포함하며,
상기 S6) 단계의 제환을 위해 곡류 및 당분을 포함한 부재료를 일절 사용하지 않는 것을 특징으로 하는,
개똥쑥 발효환의 제조방법.
S1) Screening the raw materials of the young leaves to remove impurities, washing them, and then drying them naturally in the shade for 60 days;
S2) firstly pulverizing the naturally dried raw material, and then secondly pulverizing the raw material with fine powder of 120 to 160 mesh;
S3) a) 0.1 part by weight of a dried yeast, b) 0.4 parts by weight of glucose, c) Lactobacillus acidophilus, Lactobacillus bulgaricus, Lactobacillus casei, Lactobacillus paracasei, Lactobacillus paracasei, Lactobacillus plantarum, Lactobacillus rhamnosus, Lactobacillus reuteri, Bifidobacterium bifidum, Bifidobacterium breve, longum and Streptococcus thermophillus the 12 kinds of lactic acid alpha-blending 0.05 parts by weight of the mixture at the same weight ratio, d) vegetable cream powder and maltodextrin step of mixing each of 0.225 parts by weight;
S4) preparing a mixture of yeast lactic acid bacteria by mixing the yeast extract / mixture of 12 kinds of alpha-lactic acid bacteria obtained in the step 3) in purified water at a weight ratio of 2: 8;
S5) 99 parts by weight of the secondary pulverized Sugarcane powder is placed in a fermentation vessel at 33 to 37 DEG C, inoculated with the yeast lactic acid bacteria mixture, kept in a sealed state and fermented for 3 to 6 days;
S6) a step of additionally injecting a second powder of dried Sugarcane powder in step S2) after fermentation; And
S7) low-temperature drying the pelleted fermentation broth at 45 to 50 DEG C to obtain a fermentation broth having a pelleted mugwort content of 99 wt%
Characterized in that no ingredients including cereals and sugar are used for the sake of step S6)
A method for manufacturing a fermentation product of mugwort mugwort.
상기 제조된 개똥쑥 발효환은 건강보조식품으로 사용되는 것을 특징으로 하는, 개똥쑥 발효환의 제조방법.
The method according to claim 1,
A method for producing a fermented mung bean jar, wherein the fermented mugwort fermented product is used as a health supplement.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020130160211A KR101605085B1 (en) | 2013-12-20 | 2013-12-20 | Fermented pills comprising artemisia annua and method for preparing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020130160211A KR101605085B1 (en) | 2013-12-20 | 2013-12-20 | Fermented pills comprising artemisia annua and method for preparing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20150072724A KR20150072724A (en) | 2015-06-30 |
KR101605085B1 true KR101605085B1 (en) | 2016-03-21 |
Family
ID=53518611
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020130160211A KR101605085B1 (en) | 2013-12-20 | 2013-12-20 | Fermented pills comprising artemisia annua and method for preparing the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101605085B1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101965804B1 (en) * | 2016-09-09 | 2019-04-05 | 김영훈 | Microbe Fermenting Agent for Improving Properties of Pill & Manufacturing Method of Pill for Absorption after Digestion Using the Same |
KR102083026B1 (en) * | 2017-07-20 | 2020-04-23 | 한영옥 | Manufacturing method of fermented health food using slugs |
KR102284141B1 (en) * | 2019-03-25 | 2021-08-02 | 주식회사 성진바이오 | Process of making functional rice |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002330725A (en) * | 2001-03-07 | 2002-11-19 | Ryukyu Bio Resource Kaihatsu:Kk | Fermented food material, method for producing the same, drink or food, and extract |
KR100844185B1 (en) | 2007-01-29 | 2008-07-04 | 정경식 | The manfacturing method of fermentation artemisia tea with lactic acid |
-
2013
- 2013-12-20 KR KR1020130160211A patent/KR101605085B1/en active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002330725A (en) * | 2001-03-07 | 2002-11-19 | Ryukyu Bio Resource Kaihatsu:Kk | Fermented food material, method for producing the same, drink or food, and extract |
KR100844185B1 (en) | 2007-01-29 | 2008-07-04 | 정경식 | The manfacturing method of fermentation artemisia tea with lactic acid |
Also Published As
Publication number | Publication date |
---|---|
KR20150072724A (en) | 2015-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103190626B (en) | Fruit and vegetable food for treating oral ulcer and preparation method of fruit and vegetable food | |
KR100778886B1 (en) | Preparation method of fermented fruits and vegetables, fermented fruits and vegetables prepared thereby and functional composition comprising the same | |
CN107509906B (en) | A kind of bitter buckwheat fruits and vegetables composite ferment powder and preparation method thereof | |
KR101467837B1 (en) | Manufacturing method of fermented red ginseng extract with enhanced ginsenosides Rg3 and antioxidant activity | |
KR101386879B1 (en) | Method for producing a fermentation food using mixed lactic acid bacteria and a fermentation food | |
CN105614858A (en) | Plant ferment product and preparation thereof | |
CN109846035A (en) | A kind of compound probiotic composition with body weight control | |
KR101251207B1 (en) | A method for preparing a pill or granule type fermented composition comprising the extract of complex herb useful in treating rheumatic disease | |
KR102379524B1 (en) | Composition for improving, treating or preventing intestinal function or inflammarory bowel disease comprising fermented rice as an active ingredient | |
CN101642172A (en) | Highland barley green tea and preparation method thereof | |
CN107530387B (en) | Oral composition containing Bifidobacterium and cruciferous vegetable | |
CN101548703A (en) | Highland barley green tea and preparation thereof | |
KR101605085B1 (en) | Fermented pills comprising artemisia annua and method for preparing the same | |
KR101892392B1 (en) | Composition for improving hypertension and diabetes | |
CN102300472A (en) | Symbiotic composition, and method for manufacturing same | |
CN102919956B (en) | Nutrient solution capable of nursing human digestive system and preparation method thereof | |
KR102168192B1 (en) | Healthful mixed tea development using fermented herbs, fruits and shiitake | |
KR101991623B1 (en) | Method for health food using bitter melon and embryo and mulberry leaves and oat | |
KR101581340B1 (en) | Fermentation Method for Wasong and Graviola Mixing Powder | |
KR101945207B1 (en) | Method for manufacturing a composition for enhancing intestinal environment and composition manufactured by the method | |
KR100630337B1 (en) | Process for preparing Opuntia ficus-indica fruit powder and milk product by fermentation | |
KR101421284B1 (en) | Composition for Improving Constipation and Manufacturing Method thereof | |
KR101935848B1 (en) | Food composition for improving hyperglycemia using Brassica rapa | |
KR101445573B1 (en) | Ferment solution and pill using Cundrania tricuspidata and manufacturing method of that | |
CN107693547A (en) | A kind of Preparation method and use of probiotic composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E90F | Notification of reason for final refusal | ||
E701 | Decision to grant or registration of patent right | ||
FPAY | Annual fee payment |
Payment date: 20190411 Year of fee payment: 4 |
|
R401 | Registration of restoration |